Entrepreneur Hypes AI and Deep Learning In Healthcare

Christopher Bouton, PhD, a self-described molecular neurobiologist turned entrepreneur, had such a positive experience starting and running a company that he decided to do it twice. After a five-year stint at pharmaceutical/biotech giant, Pfizer, the Johns Hopkins grad started a company called Entagen, which developed semantic-based analytics for the healthcare sector. After five years running Entagen, Thomson Reuters acquired the company in what Bouton called a "successful exit." Bouton spent a few years under the Thomson Reuters umbrella, but the entrepreneurial itch soon returned. "[In] 2016 while I was sort of contemplating what to do next, I started to take note of all of these deep learning approaches that were starting to be talked about. The reason that they're talking about AI is because of these deep learning algorithms. And so I got interested in what they were and how they worked."